Simple and rapid quantification of the non-nucleoside reverse transcriptase inhibitors nevirapine, delavirdine, and efavirenz in human blood plasma using high-performance liquid chromatography with ultraviolet absorbance detection

This publication has 18 references indexed in Scilit:

• Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients
  AIDS, 2001
• Bioanalytical Method Validation—A Revisit with a Decade of Progress
  Pharmaceutical Research, 2000
• High-Performance Liquid Chromatography Method for Analyzing the Antiretroviral Agent Efavirenz in Human Plasma
  Therapeutic Drug Monitoring, 1999
• Rapid quantification of delavirdine, a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with fluorescence detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1999
• Rapid determination of nevirapine in human plasma by ion-pair reversed-phase high-performance liquid chromatography with ultraviolet detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1998
• Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy
  Antimicrobial Agents and Chemotherapy, 1997
• Effect of fluconazole on the steady-state pharmacokinetics of delavirdine in human immunodeficiency virus-positive patients
  Antimicrobial Agents and Chemotherapy, 1997
• Protease Inhibitors in Patients with HIV Disease
  Clinical Pharmacokinetics, 1997
• L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase
  Antimicrobial Agents and Chemotherapy, 1995
• Simple, rapid and sensitive high-performance liquid chromatographic determination of delavirdine and its N-desisopropyl metabolite in human plasma
  Journal of Chromatography B: Biomedical Sciences and Applications, 1995